Stephanie A Fraga

Title: The Innovative Contributions of Stephanie A. Fraga

Introduction

Stephanie A. Fraga is a notable inventor based in Somerville, NJ (US). She has made significant contributions to the field of antimicrobial agents, holding a total of 2 patents. Her work focuses on developing effective solutions to combat bacterial infections, particularly those resistant to existing antibiotics.

Latest Patents

Fraga's latest patents include the invention of triphenylalkyl antimicrobial agents. This invention relates to triphenylalkyl antibacterial compounds that are effective in inhibiting the action of a bacterial histidine protein kinase. These compounds are useful as anti-infective agents against a variety of bacterial organisms, including those resistant to other known antibiotics. The pharmaceutical compositions containing these compounds and methods for their production and use represent a significant advancement in the fight against bacterial infections.

Career Highlights

Throughout her career, Stephanie has worked with reputable organizations, including Ortho Pharmaceutical Corporation. Her experience in the pharmaceutical industry has allowed her to develop innovative solutions that address critical health challenges.

Collaborations

Fraga has collaborated with notable professionals in her field, including James P. Demers and Sigmond G. Johnson. These collaborations have contributed to her success and the advancement of her inventions.

Conclusion

Stephanie A. Fraga's contributions to the field of antimicrobial agents highlight her innovative spirit and dedication to improving public health. Her patents represent a significant step forward in combating antibiotic-resistant bacteria, showcasing her impact as an inventor.